Results 11 to 20 of about 42,899 (196)

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

open access: yesThe Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi   +21 more
wiley   +1 more source

Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial

open access: yesBMC Cancer, 2023
Background The brain is a common site for cancer metastases. In case of large and/or symptomatic brain metastases, neurosurgical resection is performed.
Maria Waltenberger   +9 more
doaj   +1 more source

Comparison of WBRT alone, SRS alone, and their combination in the treatment of one or more brain metastases: Review and meta-analysis

open access: yesTumor Biology, 2017
Whole brain radiotherapy has been a standard treatment of brain metastases. Stereotactic radiosurgery provides more focal and aggressive radiation and normal tissue sparing but worse local and distant control.
Muhammad Khan   +7 more
doaj   +1 more source

Stereotactic Ablative Body Radiotherapy (SABR) in The Management Spinal Metastases: A Brief Overview*

open access: yesIndonesian Journal of Cancer, 2017
It is well known that radiotherapy provides successful pain relief in bone metastases. Advancements in imaging and radiotherapy delivery technology have enabled safe delivery of higher dose radiotherapy, which will produce more durable tumor control ...
HENRY KODRAT, SOEHARTATI GONDHOWIARDJO
doaj   +1 more source

LINAC stereotactic radiosurgery for trigeminal neuralgia –retrospective two-institutional examination of treatment outcomes

open access: yesRadiation Oncology, 2018
Background In this pooled 2-center series LINAC radiosurgery (SRS) has been applied as a treatment option for a subset of refractory trigeminal neuralgia (TN) patients.
Ali Rashid   +5 more
doaj   +1 more source

Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) Cost-Effectiveness Results

open access: yesFrontiers in Oncology, 2013
Objective: To describe and synthesize the current stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) cost-effectiveness research to date across several common SRS and SBRT applications.
Akash eBijlani   +3 more
doaj   +1 more source

Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?

open access: yesClinical and Translational Radiation Oncology, 2019
Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclinical data and negative clinical trials using conventional fractionated radiotherapy. However, there is emerging evidence that radiotherapy delivered in few
Alexander Rühle   +3 more
doaj   +1 more source

Stereotactic Radiosurgery/Radiotherapy: A Historical Review [PDF]

open access: yesIranian Journal of Medical Physics, 2014
"Stereotactic" is an exact radiotherapy treatment modality which implements invasive and non-invasive facilities for improving precise dose delivery. Stereotactic refers to three-dimensional localization of a specific point in space by a unique set of ...
Mansoureh Nabavi   +3 more
doaj   +1 more source

Radiotherapy management of brain metastases using conventional linear accelerator

open access: yesBiomedical Papers, 2016
Background and Aims: As treatments for primary cancers continue to improve life expectancy, unfortunately, brain metastases also appear to be constantly increasing and life expectancy for patients with brain metastases is low.
Marcel Matzenauer   +5 more
doaj   +1 more source

Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study

open access: yesRadiation Oncology, 2009
Background A phase III multi-centre randomised trial (ROSEL) has been initiated to establish the role of stereotactic radiotherapy in patients with operable stage IA lung cancer. Due to rapid changes in radiotherapy technology and evolving techniques for
van der Heide Uulke A   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy